Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» FDA, Clinical Trial Calendar Updates: Alnylam Announces Phase 1 Trial
FDA, Clinical Trial Calendar Updates: Alnylam Announces Phase 1 Trial
FDA, Clinical Trial Calendar Updates: Alnylam Announces Phase 1 Trial
Submitted by
admin
on April 7, 2009 - 9:26am
Source:
Seeking Alpha
News Tags:
FDA
drug trials
Theravance
Gilead Sciences
Teva Pharmaceuticals
Alnylam
ReNeuron
Headline:
FDA, Clinical Trial Calendar Updates: Alnylam Announces Phase 1 Trial
Do Not Allow Advertisers to Use My Personal information
